Is Xylem Inc. (XYL) a risky stock?
As of July 21, 2026, Clavix grades Xylem Inc. (XYL) A+ for risk, a composite score of 91 out of 100 on an A+ to F scale, which puts XYL in the "low risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind XYL's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how XYL scores on each, as of July 21, 2026.
What's moving XYL's risk right now
Company-specific signals Clavix flags behind XYL's current grade, drawn from recent news and filings as of July 21, 2026.
KBC Group raised its Xylem stake 30.3% in Q1, while Bank of New York Mellon trimmed its position by 2.2%. Separately, traders bought a heavy volume of XYL call options, signaling bets on a price rise.
What a A+ grade means
On the Clavix A+ to F scale, XYL's composite of 91 falls in the A band (80–100), read as "low risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell XYL or any security. Grades are risk indicators, not predictions of return. Data may be delayed.